,0
zip,01923
sector,Healthcare
fullTimeEmployees,1725
longBusinessSummary,"Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the Automated Impella Controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; and Impella BTR, a percutaneous micro heart pump with integrated motors and sensors. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts."
city,Danvers
phone,978 646 1400
state,MA
country,United States
companyOfficers,[]
website,https://www.abiomed.com
maxAge,1
address1,22 Cherry Hill Drive
fax,978 777 8411
industry,Medical Devices
ebitdaMargins,0.27996
profitMargins,0.13262
grossMargins,0.81779
operatingCashflow,292892992
revenueGrowth,0.127
operatingMargins,0.25316998
ebitda,280839008
targetLowPrice,275
recommendationKey,buy
grossProfits,685615000
freeCashflow,191921504
targetMedianPrice,390
currentPrice,318.88
earningsGrowth,-0.259
currentRatio,6.98
returnOnAssets,0.10507
numberOfAnalystOpinions,5
targetMeanPrice,365
debtToEquity,0.779
returnOnEquity,0.09875
targetHighPrice,425
totalCash,669220992
totalDebt,11165000
totalRevenue,1003148032
totalCashPerShare,14.703
financialCurrency,USD
revenuePerShare,22.108
quickRatio,5.979
recommendationMean,2.5
exchange,NMS
shortName,"ABIOMED, Inc."
longName,"Abiomed, Inc."
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,False
gmtOffSetMilliseconds,-14400000
quoteType,EQUITY
symbol,ABMD
messageBoardId,finmb_247589
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,13.813
beta3Year,
enterpriseToEbitda,49.338
52WeekChange,0.04287541
morningStarRiskRating,
forwardEps,4.62
revenueQuarterlyGrowth,
sharesOutstanding,45516200
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,31.482
sharesShort,1244595
sharesPercentSharesOut,0.0273
fundFamily,
lastFiscalYearEnd,1617148800
heldPercentInstitutions,0.941
netIncomeToCommon,133036000
trailingEps,2.909
lastDividendValue,
SandP52WeekChange,0.14403355
priceToBook,10.1289625
heldPercentInsiders,0.02024
nextFiscalYearEnd,1680220800
yield,
mostRecentQuarter,1640908800
shortRatio,4.23
sharesShortPreviousMonthDate,1644883200
floatShares,44624993
beta,1.318405
enterpriseValue,13856149504
priceHint,2
threeYearAverageReturn,
lastSplitDate,970444800
lastSplitFactor,2:1
legalType,
lastDividendDate,
morningStarOverallRating,
earningsQuarterlyGrowth,-0.26
priceToSalesTrailing12Months,14.4686575
dateShortInterest,1647302400
pegRatio,12.62
ytdReturn,
forwardPE,69.021645
lastCapGain,
shortPercentOfFloat,0.0313
sharesShortPriorMonth,1144223
impliedSharesOutstanding,0
category,
fiveYearAverageReturn,
previousClose,321.47
regularMarketOpen,323.31
twoHundredDayAverage,327.24896
trailingAnnualDividendYield,0
payoutRatio,0
volume24Hr,
regularMarketDayHigh,325
navPrice,
averageDailyVolume10Day,278210
regularMarketPreviousClose,321.47
fiftyDayAverage,302.1834
trailingAnnualDividendRate,0
open,323.31
toCurrency,
averageVolume10days,278210
expireDate,
algorithm,
dividendRate,
exDividendDate,
circulatingSupply,
startDate,
regularMarketDayLow,315.38
currency,USD
trailingPE,109.61843
regularMarketVolume,201194
lastMarket,
maxSupply,
openInterest,
marketCap,14514205696
volumeAllCurrencies,
strikePrice,
averageVolume,379417
dayLow,315.38
ask,317.79
askSize,1800
volume,201194
fiftyTwoWeekHigh,379.3
fromCurrency,
fiveYearAvgDividendYield,
fiftyTwoWeekLow,261.27
bid,250
tradeable,False
dividendYield,
bidSize,800
dayHigh,325
regularMarketPrice,318.88
preMarketPrice,
logo_url,https://logo.clearbit.com/abiomed.com
